Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 693.35

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Czechsinthemail who wrote (213)	2/22/1998 11:35:00 AM
From: scaram(o)uche	Read Replies (2) of 3559

Baird: I'm confused. I thought that it was Interneuron that parented PGEN. However, as I dig into del-1, I do find strong parallels with the tie-2 work at REGN, and even that PGEN's del-1 collaborator at Vanderbilt appears to be studying tie-2. Can you provide a pointer to the 33-37% link that you referenced? In any event, my bush-beating is providing evidence that there are similarities between angio research at PGEN and REGN. Also found a couple of weak signals.... investigators that are local to me that are studying a protein with strong homology to del-1 and with an alphaV beta3 binding motif. Probably won't pan out, but I'll follow those leads. Thanks, Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next